000			02326 a2200613 4500
005			20250517080614.0
264		0	_c20161011
008			201610s 0 0 eng d
022			_a1475-2840
024	7		_a10.1186/s12933-016-0344-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aBakhashab, Sherin
245	0	0	_aMetformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. _h[electronic resource]
260			_bCardiovascular diabetology _cFeb 2016
300			_a27 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Inducing Agents _xpharmacology
650	0	4	_aAntigens, CD34 _xmetabolism
650	0	4	_aBiomarkers _xmetabolism
650	0	4	_aCell Hypoxia
650	0	4	_aCells, Cultured
650	0	4	_aChemokine CXCL10 _xgenetics
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDown-Regulation
650	0	4	_aGene Expression Profiling
650	0	4	_aHuman Umbilical Vein Endothelial Cells _xdrug effects
650	0	4	_aHumans
650	0	4	_aHyperglycemia _xdrug therapy
650	0	4	_aHypoglycemic Agents _xpharmacology
650	0	4	_aMembrane Proteins _xgenetics
650	0	4	_aMetformin _xpharmacology
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aNeovascularization, Physiologic _xdrug effects
650	0	4	_aOxidoreductases _xgenetics
650	0	4	_aPhenotype
650	0	4	_aStem Cells _xdrug effects
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xgenetics
650	0	4	_aUp-Regulation
650	0	4	_aVascular Endothelial Growth Factor A _xgenetics
700	1		_aAhmed, Fahad W
700	1		_aSchulten, Hans-Juergen
700	1		_aBashir, Ayat
700	1		_aKarim, Sajjad
700	1		_aAl-Malki, Abdulrahman L
700	1		_aGari, Mamdooh A
700	1		_aAbuzenadah, Adel M
700	1		_aChaudhary, Adeel G
700	1		_aAlqahtani, Mohammed H
700	1		_aLary, Sahira
700	1		_aAhmed, Farid
700	1		_aWeaver, Jolanta U
773	0		_tCardiovascular diabetology _gvol. 15 _gp. 27
856	4	0	_uhttps://doi.org/10.1186/s12933-016-0344-2 _zAvailable from publisher's website
999			_c25718228 _d25718228